The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function

Cancer Cell

Volumn 26, Issue 6, 2014, Pages 923-937

  Johnston, Robert J ^a   Comps Agrar, Laetitia ^a   Hackney, Jason ^a   Yu, Xin ^a   Huseni, Mahrukh ^a   Yang, Yagai ^a   Park, Summer ^a   Javinal, Vincent ^a   Chiu, Henry ^a   Irving, Bryan ^a   Eaton, Dan L ^a   Grogan, Jane L ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD226 ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1; T LYMPHOCYTE RECEPTOR; TIGIT PROTEIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CONTROLLED STUDY; DIMERIZATION; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NEOPLASM; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; VIRAL CLEARANCE; VIRUS IMMUNITY; VIRUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; CHO CELL LINE; CRICETULUS; DISEASE MODEL; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTIC CHORIOMENINGITIS; METABOLISM; PATHOLOGY; PROTEIN MULTIMERIZATION; RAT; TUMOR CELL LINE;

MURINAE;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CHO CELLS; CRICETULUS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS; MICE; MICE, INBRED BALB C; NEOPLASMS; PROTEIN MULTIMERIZATION; RATS; RECEPTORS, IMMUNOLOGIC;

EID: 84919494669     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2014.10.018     Document Type: Article

References (48)

1. Abbas A.R., Baldwin D., Ma Y., Ouyang W., Gurney A., Martin F., Fong S., van Lookeren Campagne M., Godowski P., Williams P.M., et al. Immune response insilico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun. 2005, 6:319-331.
2. Ahmed R., Salmi A., Butler L.D., Chiller J.M., Oldstone M.B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J.Exp. Med. 1984, 160:521-540.
3. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 Tcells during chronic viral infection. Nature 2006, 439:682-687.
4. Bazin H., Trinquet E., Mathis G. Time resolved amplification of cryptate emission: a versatile technology to trace biomolecular interactions. J.Biotechnol. 2002, 82:233-250.
5. Blackburn S.D., Shin H., Haining W.N., Zou T., Workman C.J., Polley A., Betts M.R., Freeman G.J., Vignali D.A., Wherry E.J. Coregulation of CD8+ Tcell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 2009, 10:29-37.
6. Bulliard Y., Jolicoeur R., Windman M., Rue S.M., Ettenberg S., Knee D.A., Wilson N.S., Dranoff G., Brogdon J.L. Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. J.Exp. Med. 2013, 210:1685-1693.
7. Cella M., Presti R., Vermi W., Lavender K., Turnbull E., Ochsenbauer-Jambor C., Kappes J.C., Ferrari G., Kessels L., Williams I., et al. Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection. Eur. J. Immunol. 2010, 40:949-954. CHAVI Clinical Core B, NIAID Center for HIV/AIDS Vaccine ImmunologyNIAID Center for HIV/AIDS Vaccine Immunology.
8. Chen L., Flies D.B. Molecular mechanisms of Tcell co-stimulation and co-inhibition. Nat. Rev. Immunol. 2013, 13:227-242.
9. Chen D.S., Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity 2013, 39:1-10.
10. Crespo J., Sun H., Welling T.H., Tian Z., Zou W. T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr. Opin. Immunol. 2013, 25:214-221.
11. Curran M.A., Montalvo W., Yagita H., Allison J.P. PD-1 and CTLA-4 combination blockade expands infiltrating Tcells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc. Natl. Acad. Sci. USA 2010, 107:4275-4280.
12. Doering T.A., Crawford A., Angelosanto J.M., Paley M.A., Ziegler C.G., Wherry E.J. Network analysis reveals centrally connected genes and pathways involved in CD8+ Tcell exhaustion versus memory. Immunity 2012, 37:1130-1144.
13. Gallimore A., Glithero A., Godkin A., Tissot A.C., Plückthun A., Elliott T., Hengartner H., Zinkernagel R. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J.Exp. Med. 1998, 187:1383-1393.
14. Goding S.R., Wilson K.A., Xie Y., Harris K.M., Baxi A., Akpinarli A., Fulton A., Tamada K., Strome S.E., Antony P.A. Restoring immune function of tumor-specific CD4+ Tcells during recurrence of melanoma. J.Immunol. 2013, 190:4899-4909.
15. Joller N., Hafler J.P., Brynedal B., Kassam N., Spoerl S., Levin S.D., Sharpe A.H., Kuchroo V.K. Cutting edge: TIGIT has Tcell-intrinsic inhibitory functions. J.Immunol. 2011, 186:1338-1342.
16. Kalos M., June C.H. Adoptive Tcell transfer for cancer immunotherapy in the era of synthetic biology. Immunity 2013, 39:49-60.
17. Kandoth C., Schultz N., Cherniack A.D., Akbani R., Liu Y., Shen H., Robertson A.G., Pashtan I., Shen R., Benz C.C., et al. Integrated genomic characterization of endometrial carcinoma. Nature 2013, 497:67-73. Cancer Genome Atlas Research Network.
18. Keppler A., Pick H., Arrivoli C., Vogel H., Johnsson K. Labeling of fusion proteins with synthetic fluorophores in live cells. Proc. Natl. Acad. Sci. USA 2004, 101:9955-9959.
19. Krummel M.F., Allison J.P. CD28 and CTLA-4 have opposing effects on the response of Tcells to stimulation. J.Exp. Med. 1995, 182:459-465.
20. Levin S.D., Taft D.W., Brandt C.S., Bucher C., Howard E.D., Chadwick E.M., Johnston J., Hammond A., Bontadelli K., Ardourel D., et al. Vstm3 is a member of the CD28 family and an important modulator of T-cell function. Eur. J. Immunol. 2011, 41:902-915.
21. Liu S., Zhang H., Li M., Hu D., Li C., Ge B., Jin B., Fan Z. Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells. Cell Death Differ. 2013, 20:456-464.
22. Lozano E., Dominguez-Villar M., Kuchroo V., Hafler D.A. The TIGIT/CD226 axis regulates human Tcell function. J.Immunol. 2012, 188:3869-3875.
23. Maurel D., Comps-Agrar L., Brock C., Rives M.L., Bourrier E., Ayoub M.A., Bazin H., Tinel N., Durroux T., Prézeau L., et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat. Methods 2008, 5:561-567.
24. Mellman I., Coukos G., Dranoff G. Cancer immunotherapy comes of age. Nature 2011, 480:480-489.
25. Mueller S.N., Vanguri V.K., Ha S.J., West E.E., Keir M.E., Glickman J.N., Sharpe A.H., Ahmed R. PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating Tcell responses during chronic infection in mice. J.Clin. Invest. 2010, 120:2508-2515.
26. Nakamoto N., Cho H., Shaked A., Olthoff K., Valiga M.E., Kaminski M., Gostick E., Price D.A., Freeman G.J., Wherry E.J., Chang K.M. Synergistic reversal of intrahepatic HCV-specific CD8 Tcell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog. 2009, 5:e1000313.
27. Network C.G.A. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. Cancer Genome Atlas Network.
28. Network T.C.G.A. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337. Cancer Genome Atlas Network.
29. Network T.C.G.A. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012, 489:519-525. Cancer Genome Atlas Research Network.
30. Network C.G.A. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013, 499:43-49. Cancer Genome Atlas Research Network.
31. Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999, 11:141-151.
32. Palucka K., Banchereau J. Dendritic-cell-based therapeutic cancer vaccines. Immunity 2013, 39:38-48.
33. Pentcheva-Hoang T., Egen J.G., Wojnoonski K., Allison J.P. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004, 21:401-413.
34. Ramsbottom K.M., Hawkins E.D., Shimoni R., McGrath M., Chan C.J., Russell S.M., Smyth M.J., Oliaro J. Cutting edge: DNAX accessory molecule 1-deficient CD8+ Tcells display immunological synapse defects that impair antitumor immunity. J.Immunol. 2014, 192:553-557.
35. Schietinger A., Greenberg P.D. Tolerance and exhaustion: defining mechanisms of Tcell dysfunction. Trends Immunol. 2014, 35:51-60.
36. Simpson T.R., Li F., Montalvo-Ortiz W., Sepulveda M.A., Bergerhoff K., Arce F., Roddie C., Henry J.Y., Yagita H., Wolchok J.D., et al. Fc-dependent depletion of tumor-infiltrating regulatory Tcells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J.Exp. Med. 2013, 210:1695-1710.
37. Stanietsky N., Simic H., Arapovic J., Toporik A., Levy O., Novik A., Levine Z., Beiman M., Dassa L., Achdout H., et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc. Natl. Acad. Sci. USA 2009, 106:17858-17863.
38. Stanietsky N., Rovis T.L., Glasner A., Seidel E., Tsukerman P., Yamin R., Enk J., Jonjic S., Mandelboim O. Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR. Eur. J. Immunol. 2013, 43:2138-2150.
39. Stengel K.F., Harden-Bowles K., Yu X., Rouge L., Yin J., Comps-Agrar L., Wiesmann C., Bazan J.F., Eaton D.L., Grogan J.L. Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering. Proc. Natl. Acad. Sci. USA 2012, 109:5399-5404.
40. Sullivan B.M., Emonet S.F., Welch M.J., Lee A.M., Campbell K.P., de la Torre J.C., Oldstone M.B. Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc. Natl. Acad. Sci. USA 2011, 108:2969-2974.
41. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995, 3:541-547.
42. van den Boorn J.G., Hartmann G. Turning tumors into vaccines: co-opting the innate immune system. Immunity 2013, 39:27-37.
43. Welch M.J., Teijaro J.R., Lewicki H.A., Colonna M., Oldstone M.B. CD8 Tcell defect of TNF-α and IL-2 in DNAM-1 deficient mice delays clearance invivo of a persistent virus infection. Virology 2012, 429:163-170.
44. Wherry E.J. T cell exhaustion. Nat. Immunol. 2011, 12:492-499.
45. Wherry E.J., Ha S.J., Kaech S.M., Haining W.N., Sarkar S., Kalia V., Subramaniam S., Blattman J.N., Barber D.L., Ahmed R. Molecular signature of CD8+ Tcell exhaustion during chronic viral infection. Immunity 2007, 27:670-684.
46. Wolchok J.D., Kluger H., Callahan M.K., Postow M.A., Rizvi N.A., Lesokhin A.M., Segal N.H., Ariyan C.E., Gordon R.A., Reed K., et al. Nivolumab plus ipilimumab in advanced melanoma. N.Engl. J. Med. 2013, 369:122-133.
47. Yu X., Harden K., Gonzalez L.C., Francesco M., Chiang E., Irving B., Tom I., Ivelja S., Refino C.J., Clark H., et al. The surface protein TIGIT suppresses Tcell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 2009, 10:48-57.
48. Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J., Suresh M., Altman J.D., Ahmed R. Viral immune evasion due to persistence of activated Tcells without effector function. J.Exp. Med. 1998, 188:2205-2213.